For the first time, she received medical treatment from consultant of colorectal surgeon of Dhaka in a health camp at ...

Patients with BRAF V600E-mutant metastatic colorectal cancer experienced poor clinical outcomes with systemic therapy, ...

A new study has found that taking a small daily dose of aspirin could help stop colon cancer from returning in some patients.

Leap Therapeutics, Inc. (NASDAQ:LPTX) released significant updates regarding its recent clinical findings and corporate presentation. In a press release titled “Leap Therapeutics Reports Initial ...

DNA testing may inform treatment decisions and predict outcomes of adjuvant chemotherapy in patients with stage II-III colorectal cancer.

Other than a poorly timed redundancy, Tim couldn't have asked for a better retirement - surrounded by family, friends, and a ...

A group of strangers threw a wedding together in a random act of kindness for a young Kentucky woman after she received the ...

About 61% of patients with stage I or II dMMR colon cancer achieved a pathologic complete response after a single cycle of neoadjuvant pembrolizumab, new data revealed.

If the blood test - from California-based biotechnology company Freenome - was approved for market, it would be one of the ...

A new test developed in the UK can accurately predict whether high-risk patients will develop bowel cancer, also known as colorectal cancer, in the five years.

Chemotherapy has been known to cause damage to peripheral nerves, and sometimes the pain is chronic and severe enough that chemotherapy doses are reduced or discontinued. But prior research has not ...

The combination of Opdivo and Yervoy is supported by updated results as a standard of care for MSI-H or dMMR metastatic ...